The Effectiveness of Acceptance and Commitment Therapy on Depression in Multiple Sclerosis

Main Article Content

Elham Zamani
Abdollah Moatamedy
Maryam Bakhtiari

Abstract

The main purpose of this research was to evaluate the effectiveness of acceptance and commitment therapy on depression in patients with Multiple Sclerosis( MS) .This research was carried out based on questionnaire survey and Beck Depression Inventory. The method of the experimental design of pretest - posttest control group design was used. The respondents of the survey were chosen from members of MS Tehran and classified in two experimental/control groups. The data were analyzed using Statistical Packages for Social Sciences (SPSS).Results showed that pre-test and post-test scores of depression in patients with MS significantly different (P <0.05) and follow-up (P <0.01) .In other words, reduce depressive symptoms in patients with MS in the test in follow up period has survived.It can be concluded that treatment acceptance and commitment therapy is effective in reducing depression in patients with multiple sclerosis. 

Downloads

Download data is not yet available.

Article Details

How to Cite
Zamani, E., Moatamedy, A., & Bakhtiari, M. (2021). The Effectiveness of Acceptance and Commitment Therapy on Depression in Multiple Sclerosis. New Trends and Issues Proceedings on Humanities and Social Sciences, 3(2), 53–58. https://doi.org/10.18844/prosoc.v3i2.1599 (Original work published March 22, 2017)
Section
Articles

References

Cardaciotto, L.A. (2005). Assessing mindfulness: The development of a bi-dimensional measure of awareness and acceptance [Thesis]. Philadelphia, PA: Drexel University

Comabella, M. & Khoury, S.J. (2011). Immunopathogenesis of multiple sclerosis. Clin Immunol 142, 2–8. In M.J. AMINOFF, F. BOLLER, D.F. SWAAB, (Eds.). Handbook of Clinical Neurology. The Netherlands: Elsevier.

Compston, A., Confavreux, C., Lassmann, H. & et al. (2006). McAlpine’s multiple sclerosis. 4th edn. Churchill Livingstone, London. In M.J. AMINOFF, F. BOLLER, D.F. SWAAB, (Eds.), Handbook of Clinical Neurology. The Netherlands: Elsevier.

Gelfand, J.M. (2014). Multiple sclerosis: Diagnosis, differential diagnosis, and clinical presentation. In M.J. AMINOFF, F. BOLLER, D.F. SWAAB, (Eds.), Handbook of clinical neurology. The Netherlands: Elsevier.

Hayes, S.C., Strosahl, K. & Wilson, K.G. (1999). Acceptance and commitment therapy: An experiential approach to behavior change. New York: Guildford Press

Hayes, S.C., Levin, M.E., Plumb-Vilardaga, J., Villatte, J.L. & Pistorello, J. (2013). Acceptance and commitment therapy and contextual behavioral science: Examining the progress of a distinctive model of behavioral and cognitive therapy. Behav Ther, 44(2), 180–198

Herbert, J.D. & Forman, E.M. (Eds). (2011). Acceptance and mindfulness in cognitive behavior therapy. Hopken, NJL: Wiley

Holland, N.J. & Halper, J. (2005). Multiple sclerosis: a selfcare guide to wellness. New York: Demos Medical Publishing, 1-10.

Izadi, R. & Abedi M.R. (2013). Alleviation of obsessive symptoms in treatment-resistant obsessivecompulsive disorder using acceptance and commitment-based therapy. Feyz, Journal of Kashan University of Medical Sciences, 17(3), 275-286.

Izadi, R., Asgari, K., Neshatdust, H. & Abedi, M. (2012). The effect of acceptance and commitment therapy on the frequency and severity of symptoms of obsessive compulsive disorder. Zahedan Journal of Research in Medical Sciences.

Luciano, J.V., Guallar, J.A., Aguado, J., López-del-Hoyo, Y., Olivan, B., Magallón, R., Alda, M., Serrano-Blanco, A., Gili, M. & Garcia-Campayo, J. (2013). Effectiveness of group acceptance and commitment therapy for fibromyalgia: A 6-month randomized controlled trial (EFFIGACT study). International Association for the Study of Pain. Published by Elsevier B.V.

Marrie, R.A., Fisk, J.D., Yu, B.N., Leung, S., Elliott, L., Caetano, P., Warren, S., Evans, C., Wolfson, C., Svenson, L.W., Tremlett, H., Blanchard, J.F. & Patten, S.B. (2013). Mental comorbidity and multiple sclerosis: Validating administrative data to support population-based surveillance. BMC Neurology, 13, 16.

Minden, S.L., (2000). Mood disorders in multiple sclerosis: Diagnosis and treatment. Journal of NeuroVirology 6, 160-167.

Nordin, L. & Rorsman, I. (2012). Cognitive behavioral therapy in multiple sclerosis: A randomized controlled pilot study of acceptance and commitment therapy. J Rehabil Med 44, 87–90.

Pirkhaefi, A. & Nida, S. (2013). Acceptance and commitment therapy for OCD, and depression: A Case Study. Journal of Behavioral sciences in Asia, 1(2), pp. 16-25.

Randolph, B. & Schiffer, M.D. (2005). The Goldman Consensus statement on depression in multiple sclerosis. Multiple Sclerosis, 113, 28-337

Sarısoy, G., Terzi, M., Gumuş, K. & Pazvantoglu, O. (2012). Psychiatric symptoms in patients with multiple sclerosis. General Hospital Psychiatry, 35, 134–140

Sriram, S. Steiner, I. (2005). Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol 58: 939–945. In M.J. AMINOFF, F. BOLLER, D.F. SWAAB, (Eds.). Handbook of Clinical Neurology. The Netherlands: Elsevier.

Thomas, P.W., Thomas, S., Hillier, Ch., Galvin, K. & Baker, R. (2005). Psychological interventions for multiple sclerosis. Cochrane Database of Systematic Reviews. New York: Wiley.